Novartis gets $6.5m from Gates Foundation for diarrhoea drug
Novartis and the Bill & Melinda Gates Foundation are teaming up to advance development of the drug giant’s experimental therapy KDU731 for the treatment of infectious diarrhoea cryptosporidiosis.
Read More
